Polycystic liver disease is a disorder of cotranslational protein processing

Trends in Molecular Medicine

Volumn 11, Issue 1, 2005, Pages 37-42

  Drenth, Joost P H ^a,b   Martina, Jose A ^b   Kerkhof, Rolf Van De ^a   Bonifacino, Juan S ^b   Jansen, Jan B M J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; OLIGOSACCHARIDE; PROTEIN KINASE C; PROTEIN SUBUNIT;

BETA CHAIN; CELL GROWTH; CHROMOSOME TRANSLOCATION; DIAGNOSTIC PROCEDURE; ENDOPLASMIC RETICULUM; GENE IDENTIFICATION; GENETIC HETEROGENEITY; GLYCOSYLATION; HUMAN; LIVER POLYCYSTIC DISEASE; MEDICAL RESEARCH; NONHUMAN; PHENOTYPE; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN PROCESSING; QUALITY CONTROL; REVIEW; TRANSLATION INITIATION;

ALPHA-GLUCOSIDASES; CYSTS; ENDOPLASMIC RETICULUM; GLUCOSIDASES; GLYCOSYLATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER DISEASES; MEMBRANE PROTEINS; MUTATION; PHOSPHOPROTEINS; PROTEIN MODIFICATION, TRANSLATIONAL;

EID: 11844282749     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2004.11.004     Document Type: Review

References (30)

1. Q. Qian Clinical profile of autosomal dominant polycystic liver disease Hepatology 37 2003 164 171
2. D.J. Peters, and M.H. Breuning Autosomal dominant polycystic kidney disease: modification of disease progression Lancet 358 2001 1439 1444
3. G.T. Everson Polycystic disease of the liver Hepatology 40 2004 774 782
4. V.E. Torres Polycystic liver disease Contrib. Nephrol. 115 1995 44 52
5. E.W. Gieteling, and G.J. Rinkel Characteristics of intracranial aneurysms and subarachnoid haemorrhage in patients with polycystic kidney disease J. Neurol. 250 2003 418 423
6. G.S. Yang Combined hepatic resection with fenestration for highly symptomatic polycystic liver disease: A report on seven patients World J. Gastroenterol. 10 2004 2598 2601
7. K. Ishibashi Is fenestration a safe treatment for adult polycystic liver disease? A report of refractory complications Hepatogastroenterology 51 2004 1165 1167
8. Y. Ubara Intravascular embolization therapy in a patient with an enlarged polycystic liver Am. J. Kidney Dis. 43 2004 733 738
9. M. Ueda Living-donor liver transplantation for polycystic liver disease Transplantation 77 2004 480 481
10. D.M. Reynolds Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1 Am. J. Hum. Genet. 67 2000 1598 1604
11. J.P. Drenth Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease Nat. Genet. 33 2003 345 347
12. A. Li Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease Am. J. Hum. Genet. 72 2003 691 703
13. S. Davila Mutations in SEC63 cause autosomal dominant polycystic liver disease Nat. Genet. 36 2004 575 577
14. J.P. Drenth Abnormal hepatocystin caused by truncating PRKCSH mutations leads to autosomal dominant polycystic liver disease Hepatology 39 2004 924 931
15. P. Tahvanainen Polycystic liver disease is genetically heterogeneous: clinical and linkage studies in eight Finnish families J. Hepatol. 38 2003 39 43
16. 2+ channel transient receptor potential cation channel V5 (TRPV5) J. Biol. Chem. 279 2004 26351 26357
17. C. D'Alessio Genetic evidence for the heterodimeric structure of glucosidase II. The effect of disrupting the subunit-encoding genes on glycoprotein folding J. Biol. Chem. 274 1999 25899 25905
18. J.P. Drenth Molecular characterization of hepatocystin, the protein that is defective in autosomal dominant polycystic liver disease Gastroenterology 126 2004 1819 1827
19. M.H. Skowronek Molecular characterization of a novel mammalian DnaJ-like Sec63p homolog Biol. Chem. 380 1999 1133 1138
20. J.A. Rothblatt Multiple genes are required for proper insertion of secretory proteins into the endoplasmic reticulum in yeast J. Cell Biol. 109 1989 2641 2652
21. M. Willer An in vitro assay using overexpressed yeast SRP demonstrates that cotranslational translocation is dependent upon the J-domain of Sec63p Biochemistry 42 2003 7171 7177
22. C.M. de Praeter A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency Am. J. Hum. Genet. 66 2000 1744 1756
23. A. Helenius, and M. Aebi Roles of N-linked glycans in the endoplasmic reticulum Annu. Rev. Biochem. 73 2004 1019 1049
24. J.X. Zhang Quality control in the secretory pathway: the role of calreticulin, calnexin and BiP in the retention of glycoproteins with C-terminal truncations Mol. Biol. Cell 8 1997 1943 1954
25. J.H. Christensen Impaired trafficking of mutated AVP prohormone in cells expressing rare disease genes causing autosomal dominant familial neurohypophyseal diabetes insipidus Clin. Endocrinol. (Oxf.) 60 2004 125 136
26. B.K. Yoder The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia J. Am. Soc. Nephrol. 13 2002 2508 2516
27. S.M. Nauli Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells Nat. Genet. 33 2003 129 137
28. H.F. Cantiello A tale of two tails: ciliary mechanotransduction in ADPKD Trends Mol. Med. 9 2003 234 236
29. Y. Pei A 'two-hit' model of cystogenesis in autosomal dominant polycystic kidney disease? Trends Mol. Med. 7 2001 151 156
30. Y. Pei Somatic PKD2 mutations in individual kidney and liver cysts support a 'two-hit' model of cystogenesis in type 2 autosomal dominant polycystic kidney disease J. Am. Soc. Nephrol. 10 1999 1524 1529